This symposium will address methods of obtaining patent terms that extend beyond the normal 20-year terms afforded by most countries.  The Hatch-Waxman regime in the U.S. provides a system for awarding extensions to patent term for drug products that have been subjected to a regulatory approval process.  Patent Term Adjustment is now also a key component of a strategy to extend U.S. patent term.  Other countries worldwide offer Supplementary Protection Certificates to provide patentees with extended coverage for products that have received marketing authorization.  These provisions, when coupled with data exclusivity possibilities, provide a valuable extension of rights for approved drug products.

Extensions to patent term in the U.S. and worldwide

256th National Meeting (2018)

The official archive and repository for all ACS Meetings & Expositions abstracts and select posters or presentations.